HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term survival and reversal of iron overload after marrow transplantation in dogs with congenital hemolytic anemia.

Abstract
Severe hemolytic in Basenji dogs secondary to pyruvate kinase deficiency was corrected by marrow transplantation from hematologically normal littermates. These dogs have now been followed for more than 5.5 yr. Essentially normal hematopoiesis has persisted, and the dogs remain in good health without cirrhosis or osteosclerosis. Furthermore, hepatic iron overload present before transplantation has gradually decreased. These results in dogs suggest that marrow transplantation could prevent the morbidity and mortality of severe hemolytic anemia and associated iron overload in man.
AuthorsP L Weiden, R C Hackman, H J Deeg, T C Graham, E D Thomas, R Storb
JournalBlood (Blood) Vol. 57 Issue 1 Pg. 66-70 (Jan 1981) ISSN: 0006-4971 [Print] United States
PMID6778539 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Iron
Topics
  • Anemia, Hemolytic, Congenital (mortality, therapy)
  • Animals
  • Bone Marrow (pathology)
  • Bone Marrow Transplantation
  • Dogs
  • Erythrocyte Aging
  • Hematocrit
  • Iron (metabolism)
  • Liver (metabolism, pathology)
  • Long-Term Care
  • Skin (pathology)
  • Spleen (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: